Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 62.52B 9.31B 8.06B 7.63B 6.9B 12.96B 893B 13.05B 91B 35.01B 453B 34.97B 34.2B 1,444B | P/E 2026 * |
47.2x | P/E 2027 * | 35.6x |
|---|---|---|---|---|---|
| Enterprise Value | 57.85B 8.61B 7.46B 7.06B 6.39B 11.99B 826B 12.08B 84.2B 32.39B 419B 32.36B 31.64B 1,336B | EV / Sales 2026 * |
7.15x | EV / Sales 2027 * | 6x |
| Free-Float |
61.13% | Yield 2026 * |
0.76% | Yield 2027 * | 1.02% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 9.31B | ||
| -0.19% | +1.09% | +51.85% | +97.36% | 1,013B | ||
| +0.33% | -0.71% | +50.62% | +65.50% | 644B | ||
| +0.49% | +5.73% | +20.88% | +72.92% | 465B | ||
| -0.22% | +2.88% | +38.48% | +37.98% | 352B | ||
| -0.07% | +1.82% | +16.57% | +23.39% | 264B | ||
| -0.31% | +2.02% | +6.15% | +10.75% | 253B | ||
| -1.53% | -4.46% | +36.90% | +44.08% | 203B | ||
| -1.60% | -5.51% | -22.30% | -58.60% | 188B | ||
| +0.49% | -0.23% | +30.00% | +93.34% | 181B | ||
| Average | -0.07% | -1.08% | +25.46% | +42.97% | 395.97B | |
| Weighted average by Cap. | +0.40% | +0.01% | +34.52% | +59.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.2B 1.04B 987M 893M 1.68B 116B 1.69B 11.77B 4.53B 58.59B 4.52B 4.42B 187B | 9.8B 1.46B 1.26B 1.2B 1.08B 2.03B 140B 2.05B 14.27B 5.49B 71B 5.48B 5.36B 226B |
| Net income | 1.41B 210M 182M 172M 156M 293M 20.17B 295M 2.05B 791M 10.23B 790M 772M 32.61B | 1.82B 271M 234M 222M 201M 377M 25.96B 380M 2.65B 1.02B 13.16B 1.02B 994M 41.98B |
| Net Debt | -4.67B -696M -603M -570M -516M -969M -66.76B -976M -6.8B -2.62B -33.85B -2.61B -2.56B -108B | -3.66B -544M -472M -446M -404M -758M -52.22B -763M -5.32B -2.05B -26.48B -2.04B -2B -84.45B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
















